Approaches to the pathogenesis of primary biliary cirrhosis through animal models

Clinics and Research in Hepatology and Gastroenterology

Volumn 36, Issue 1, 2012, Pages 21-28

  Concepcion, Axel R ^a   Medina, Juan F ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2 OCTYNOIC ACID; 6 BROMOHEXANOATE; ALKALINE PHOSPHATASE; BOVINE SERUM ALBUMIN; HEXANOIC ACID; IMMUNOGLOBULIN M; INTERLEUKIN 2 RECEPTOR; POLYINOSINIC POLYCYTIDYLIC ACID; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; GENETICS; GRAM NEGATIVE BACTERIUM; HUMAN; LIVER FIBROSIS; LIVER GRANULOMA; LYMPHOCYTIC INFILTRATION; NONHUMAN; NOVOSPHINGOBIUM AROMATICIVORAN; OXIDATIVE STRESS; PATHOGENESIS; PRIMARY BILIARY CIRRHOSIS; RABBIT; REGULATORY T LYMPHOCYTE; SENSITIZATION; SHORT SURVEY; SWINE;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; BIOLOGICAL MARKERS; EVIDENCE-BASED MEDICINE; HUMANS; LIVER CIRRHOSIS, BILIARY; MICE; MITOCHONDRIA; MODELS, ANIMAL; T-LYMPHOCYTES;

EID: 84856693038     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2011.07.007     Document Type: Short Survey

References (74)

1. Poupon R. Primary biliary cirrhosis: a 2010 update. J Hepatol 2010, 52:745-758.
2. Hohenester S., Oude-Elferink R.P.J., Beuers U. Primary biliary cirrhosis. Semin Immunopathol 2009, 31:283-307.
3. Kaplan M.M., Gershwin M.E. Primary biliary cirrhosis. N Engl J Med 2005, 353:1261-1273.
4. He X.S., Ansari A.A., Ridgway W.M., Coppel R.L., Gershwin M.E. New insights to the immunopathology and autoimmune responses in primary biliary cirrhosis. Cell Immunol 2006, 239:1-13.
5. Jones D.E. Pathogenesis of primary biliary cirrhosis. Gut 2007, 56:1615-1624.
6. Gershwin M.E., Mackay I.R. The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 2008, 47:737-745.
7. Tison V., Callea F., Morisi C., Mancini A.M., Desmet V.J. Spontaneous primary biliary cirrhosis in rabbits. Liver 1982, 2:152-161.
8. Hayashi Y., Utsuyama M., Kurashima C., Hirokawa K. Spontaneous development of organ-specific autoimmune lesions in aged C57BL/6 mice. Clin Exp Immunol 1989, 78:120-126.
9. Kanda K., Onji M., Ohta Y. Spontaneous occurrence of autoimmune cholangitis in senescent mice. J Gastroenterol Hepatol 1993, 8:7-14.
10. Tsuneyama K., Nose M., Nisihara M., Katayanagi K., Harada K., Nakanuma Y. Spontaneous occurrence of chronic non-suppurative destructive cholangitis and antimitochondrial autoantibodies in MRL/lpr mice: possible animal model for primary biliary cirrhosis. Pathol Int 2001, 51:418-424.
11. Hamano H., Saito I., Haneji N., Mitsuhashi Y., Miyasaka N., Hayashi Y. Expressions of cytokine genes during development of autoimmune sialadenitis in MRL/lpr mice. Eur J Immunol 1993, 23:2387-2391.
12. Hayashi Y., Haneji N., Hamano H. Cytokine gene expression and autoantibody production in Sjogren's syndrome of MRL/lpr mice. Autoimmunity 1996, 23:269-277.
13. Ohba K., Omagari K., Murase K., et al. A possible mouse model for spontaneous cholangitis: serological and histological characteristics of MRL/lpr mice. Pathology 2002, 34:250-256.
14. Jones D.E., Palmer J.M., Kirby J.A., et al. Experimental autoimmune cholangitis: a mouse model of immune-mediated cholangiopathy. Liver 2000, 20:351-356.
15. Jones D.E., Palmer J.M., Yeaman S.J., Kirby J.A., Bassendine M.F. Breakdown of tolerance to pyruvate dehydrogenase complex in experimental autoimmune cholangitis: a mouse model of primary biliary cirrhosis. Hepatology 1999, 30:65-70.
16. Sasaki M., Allina J., Odin J.A., et al. Autoimmune cholangitis in the SJL/J mouse is antigen non-specific. Dev Immunol 2002, 9:103-111.
17. Sasaki M., Long S.A., Van De Water J., et al. The SJL/J mouse is not a model for PBC. Hepatology 2002, 35:1284-1286.
18. Ueno Y., Moritoki Y., Shimosegawa T., Gershwin M.E. Primary biliary cirrhosis: what we know and what we want to know about human PBC and spontaneous PBC mouse models. J Gastroenterol 2007, 42:189-195.
19. Chuang Y.H., Ridgway W.M., Ueno Y., Gershwin M.E. Animal models of primary biliary cirrhosis. Clin Liver Dis 2008, 12:333-347. [ix].
20. Selmi C., Meda F., Kasangian A., et al. Experimental evidence on the immunopathogenesis of primary biliary cirrhosis. Cell Mol Immunol 2010, 7:1-10.
21. Ueno Y., Ambrosini Y.M., Moritoki Y., Ridgway W.M., Gershwin M.E. Murine models of autoimmune cholangitis. Curr Opin Gastroenterol 2010, 26:274-279.
22. Trauner M., Fickert P., Baghdasaryan A., et al. New insights into autoimmune cholangitis through animal models. Dig Dis 2010, 28:99-104.
23. Invernizzi P., Selmi C., Gershwin M.E. Update on primary biliary cirrhosis. Dig Liver Dis 2010, 42:401-408.
24. Selmi C., Mackay I.R., Gershwin M.E. The autoimmunity of primary biliary cirrhosis and the clonal selection theory. Immunol Cell Biol 2011, 89:70-80.
25. Okada C., Akbar S.M., Horiike N., Onji M. Early development of primary biliary cirrhosis in female C57BL/6 mice because of poly I:C administration. Liver Int 2005, 25:595-603.
26. Wang D., Zhang H., Liang J., et al. Effect of allogeneic bone marrow-derived mesenchymal stem cells transplantation in a polyI:C-induced primary biliary cirrhosis mouse model. Clin Exp Med 2011, 11:25-32.
27. Lan R.Y., Cheng C., Lian Z.X., et al. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology 2006, 43:729-737.
28. Leung P.S., Quan C., Park O., et al. Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies. J Immunol 2003, 170:5326-5332.
29. Leung P.S., Park O., Tsuneyama K., et al. Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization. J Immunol 2007, 179:2651-2657.
30. Amano K., Leung P.S., Rieger R., et al. Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol 2005, 174:5874-5883.
31. Wakabayashi K., Lian Z.X., Leung P.S., et al. Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology 2008, 48:531-540.
32. Wu S.J., Yang Y.H., Tsuneyama K., et al. Innate immunity and primary biliary cirrhosis: activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis. Hepatology 2011, 53:915-925.
33. Selmi C., Balkwill D.L., Invernizzi P., et al. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology 2003, 38:1250-1257.
34. Padgett K.A., Selmi C., Kenny T.P., et al. Phylogenetic and immunological definition of four lipoylated proteins from Novosphingobium aromaticivorans, implications for primary biliary cirrhosis. J Autoimmun 2005, 24:209-219.
35. Kaplan M.M. Novosphingobium aromaticivorans: a potential initiator of primary biliary cirrhosis. Am J Gastroenterol 2004, 99:2147-2149.
36. Mattner J., Savage P.B., Leung P., et al. Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe 2008, 3:304-315.
37. Lyons P.A., Hancock W.W., Denny P., et al. The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137. Immunity 2000, 13:107-115.
38. Bach J.F., Mathis D. The NOD mouse. Res Immunol 1997, 148:285-286.
39. Koarada S., Wu Y., Fertig N., et al. Genetic control of autoimmunity: protection from diabetes, but spontaneous autoimmune biliary disease in a nonobese diabetic congenic strain. J Immunol 2004, 173:2315-2323.
40. Irie J., Wu Y., Wicker L.S., et al. NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. J Exp Med 2006, 203:1209-1219.
41. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med 2003, 198:1875-1886.
42. Peng J., Dicker B., Du W., et al. Converting antigen-specific diabetogenic CD4 and CD8 T cells to TGF-beta producing non-pathogenic regulatory cells following FoxP3 transduction. J Autoimmun 2007, 28:188-200.
43. Shull M.M., Ormsby I., Kier A.B., et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 1992, 359:693-699.
44. Kulkarni A.B., Huh C.G., Becker D., et al. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A 1993, 90:770-774.
45. Kaartinen V., Voncken J.W., Shuler C., et al. Abnormal lung development and cleft palate in mice lacking TGF-β3 indicates defects of epithelial-mesenchymal interaction. Nat Genet 1995, 11:415-421.
46. Proetzel G., Pawlowski S.A., Wiles M.V., et al. Transforming growth factor-β3 is required for secondary palate fusion. Nat Genet 1995, 11:409-414.
47. Sanford L.P., Ormsby I., Gittenberger-de Groot A.C., et al. TGFβ2 knockout mice have multiple developmental defects that are non-overlapping with other TGFβ knockout phenotypes. Development 1997, 124:2659-2670.
48. Gorelik L., Flavell R.A. Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 2000, 12:171-181.
49. Oertelt S., Lian Z.X., Cheng C.M., et al. Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-β receptor II dominant-negative mice. J Immunol 2006, 177:1655-1660.
50. + regulatory T cells. J Exp Med 2005, 201:1061-1067.
51. Willerford D.M., Chen J., Ferry J.A., Davidson L., Ma A., Alt F.W. Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment. Immunity 1995, 3:521-530.
52. -/-mice and the development of primary biliary cirrhosis. Hepatology 2006, 44:1240-1249.
53. Aoki C.A., Roifman C.M., Lian Z.X., et al. IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun 2006, 27:50-53.
54. -/- mice. Hepatology 2009, 49:133-140.
55. + regulatory T cells in human autoimmune diseases. Nat Rev Immunol 2010, 10:849-859.
56. Brunkow M.E., Jeffery E.W., Hjerrild K.A., et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001, 27:68-73.
57. Zhang W., Sharma R., Ju S.T., et al. Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis. Hepatology 2009, 49:545-552.
58. Corpechot C., Carrat F., Bahr A., Chretien Y., Poupon R.E., Poupon R. The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology 2005, 128:297-303.
59. Parés A., Caballería L., Rodés J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid. Gastroenterology 2006, 130:715-720.
60. Lindor K. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. N Engl J Med 2007, 357:1524-1529.
61. Prieto J., Qian C., Garcia N., Diez J., Medina J.F. Abnormal expression of anion exchanger genes in primary biliary cirrhosis. Gastroenterology 1993, 105:572-578.
62. Banales J.M., Arenas F., Rodríguez-Ortigosa C.M., et al. Bicarbonate-rich choleresis induced by secretin in normal rat is taurocholate-dependent and involves AE2 anion exchanger. Hepatology 2006, 43:266-275.
63. - exchange. Hepatology 2010, 51:891-902.
64. Martínez-Ansó E., Castillo J.E., Díez J., Medina J.F., Prieto J. Immunohistochemical detection of chloride/bicarbonate anion exchangers in human liver. Hepatology 1994, 19:1400-1406.
65. García C., Montuenga L.M., Medina J.F., Prieto J. In situ detection of AE2 anion-exchanger mRNA in the human liver. Cell Tissue Res 1998, 291:481-488.
66. Medina J.F., Martínez-Ansó E., Vázquez J.J., Prieto J. Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis. Hepatology 1997, 25:12-17.
67. + exchanger activities in primary biliary cirrhosis. Hepatology 2002, 35:1513-1521.
68. Medina J.F., Recalde S., Prieto J., et al. Anion exchanger 2 is essential for spermiogenesis in mice. Proc Natl Acad Sci U S A 2003, 100:15847-15852.
69. a,b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis. Gastroenterology 2008, 134:1482-1493.
70. Fickert P., Trauner M. When lightning strikes twice: the plot thickens for a dual role of the anion exchanger 2 (AE2/SLC4A2) in the pathogenesis and treatment of primary biliary cirrhosis. J Hepatol 2009, 50:633-635.
71. - umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies. Hepatology 2010, 52:1334-1340.
72. -/- mice. Am J Pathol 2006, 169:165-176.
73. a,b-deficient mice exhibit osteopetrosis of long bones but not of calvaria. Faseb J 2009, 23:3470-3481.
74. Bronckers A.L., Lyaruu D.M., Jansen I.D., et al. Localization and function of the anion exchanger Ae2 in developing teeth and orofacial bone in rodents. J Exp Zool B Mol Dev Evol 2009, 312B:375-387.